Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Intracanal use of a corticosteroid-antibiotic compound for the management of posttreatment endodontic pain
Autore:
Negm, MM;
Indirizzi:
Cairo Univ, Fac Oral & Dent Med, Dept Endodont, Cairo, Egypt Cairo Univ Cairo Egypt Fac Oral & Dent Med, Dept Endodont, Cairo, Egypt
Titolo Testata:
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
fascicolo: 4, volume: 92, anno: 2001,
pagine: 435 - 439
SICI:
1079-2104(200110)92:4<435:IUOACC>2.0.ZU;2-B
Fonte:
ISI
Lingua:
ENG
Soggetto:
DOUBLE-BLIND; THERAPY; TEETH; DEXAMETHASONE; AGENTS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
26
Recensione:
Indirizzi per estratti:
Indirizzo: Negm, MM Cairo Univ, Fac Oral & Dent Med, Dept Endodont, Cairo, Egypt Cairo Univ Cairo Egypt & Dent Med, Dept Endodont, Cairo, Egypt
Citazione:
M.M. Negm, "Intracanal use of a corticosteroid-antibiotic compound for the management of posttreatment endodontic pain", ORAL SURG O, 92(4), 2001, pp. 435-439

Abstract

Objective. The purpose of this randomized, double-blind study was to determine the effect of a corticosteroid-antibiotic combination when used as an intracanal medicament for the treatment of posttreatment pain in endodontically involved teeth with vital pulp-test readings. Study design. Out of 988 patients, 480 experienced intratreatment pain. Endodontic treatment was completed in 3 visits. Patients who experienced painafter the first or second visit (postextirpation or postinstrumentation) were given an emergency visit during which no local anesthetic was used. Thepatients randomly received either intracanal corticosteroid-antibiotic compound or a placebo. Patients subjectively rated their pain on a scale of 1 to 4 as none, mild, moderate, and severe. The ratings were done at 1, 2, 4,8, 12, and 24 hours postmedication. Results. Intracanal use of the corticosteroid-antibiotic medication significantly reduced (P < .001) the mean pain score quite rapidly and was significantly superior to the placebo until the end of the study (P < .001). Furthermore, there were no reoccurrences of pain, and no side effects from use of the drug were noted. Conclusion. These results support the intracanal use of corticosteroid-anti biotic combination for controlling posttreatment endodontic pain.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/04/20 alle ore 12:05:47